|
This instrument specifies, for the purposes of paragraph 3(5)(ca) of the Therapeutic Goods Act 1989, advisory statements which are required to be included on the label of over the counter medicines and registered complementary medicines. If such statements are not included on the label of these medicines as required, the presentation of the product may be unacceptable. This instrument also repeals and replaces the Medicines Advisory Statements Specification 2017.
|